Compare SGHT & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHT | III |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | 1500 |
| Industry | Medical Specialities | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 235.0M | 203.8M |
| IPO Year | 2021 | 2006 |
| Metric | SGHT | III |
|---|---|---|
| Price | $5.02 | $4.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $9.08 | $5.50 |
| AVG Volume (30 Days) | 126.9K | ★ 206.3K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.46% |
| EPS Growth | 28.16 | ★ 216.67 |
| EPS | N/A | ★ 0.05 |
| Revenue | $77,363,000.00 | ★ $192,745,000.00 |
| Revenue This Year | $11.67 | $3.85 |
| Revenue Next Year | $10.39 | $4.34 |
| P/E Ratio | ★ N/A | $84.20 |
| Revenue Growth | N/A | ★ 4.51 |
| 52 Week Low | $3.11 | $3.74 |
| 52 Week High | $9.24 | $6.45 |
| Indicator | SGHT | III |
|---|---|---|
| Relative Strength Index (RSI) | 56.42 | 41.20 |
| Support Level | $4.76 | $3.95 |
| Resistance Level | $5.25 | $4.37 |
| Average True Range (ATR) | 0.29 | 0.13 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 73.73 | 11.22 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.